Brief: CanariaBio Inc Announces Enrollment Completion of randomized Phase 2 study of Oregovomab in combination with chemotherapy as neo-adjuvant treatment of patients with Advanced Ovarian Cancer23/08/2024 13:06
Brief: Canariabio Achieves Significant Milestone With FDA's Orphan Drug Designation For Mab-Ar20.5 Targeting Pancreatic Cancer21/08/2023 13:21
Last trade - 00:00Last trade - 00:00Last trade - 00:00